Ventyx Biosciences Files 8-K

Ventyx Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyVentyx Biosciences, Inc.
Form Type8-K
Filed DateOct 22, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, 8-K, regulatory-disclosure

TL;DR

Ventyx Biosciences dropped an 8-K on 10/22/25. Check it for corporate updates.

AI Summary

Ventyx Biosciences, Inc. filed an 8-K on October 22, 2025, reporting on various events and financial statements. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in San Diego, California.

Why It Matters

This 8-K filing provides an official update on Ventyx Biosciences' corporate status and events, which is crucial for investors and stakeholders to stay informed about the company's regulatory compliance and operational disclosures.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.

Key Numbers

  • 001-40928 — Commission File Number (SEC File Number for Ventyx Biosciences)
  • 83-2996852 — IRS Employer Identification No. (Tax Identification Number for Ventyx Biosciences)

Key Players & Entities

  • Ventyx Biosciences, Inc. (company) — Registrant
  • October 22, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • San Diego, California (location) — Address of Principal Executive Offices
  • 760 407-6511 (phone_number) — Registrant's Telephone Number

FAQ

What is the primary purpose of this 8-K filing for Ventyx Biosciences?

This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on various events and financial statements as of October 22, 2025.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on October 22, 2025.

In which state is Ventyx Biosciences, Inc. incorporated?

Ventyx Biosciences, Inc. is incorporated in Delaware.

What is the address of Ventyx Biosciences' principal executive offices?

The principal executive offices of Ventyx Biosciences are located at 12790 El Camino Real Suite 200, San Diego, California, 92130.

What is the Commission File Number for Ventyx Biosciences?

The Commission File Number for Ventyx Biosciences is 001-40928.

Filing Stats: 615 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-10-22 16:19:05

Key Financial Figures

  • $0.0001 — nge on which registered Common Stock, $0.0001 par value per share VTYX The Nasdaq

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated October 22, 2025. 99.2 Phase 2 Trial of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors Topline Results Presentation, dated October 22, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VENTYX BIOSCIENCES, INC. Date: October 22, 2025 By: /s/ Raju Mohan Raju Mohan, Ph.D. Chief Executive Officer and Director (Principal Executive Officer) 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.